Acute bacterial meningitis (ABM) continues to be associated with high mortality and morbidity, despite advances in antimicrobial therapy. The causative organism varies with age, immune function, immunization status, and geographic region, and empiric therapy for meningitis is based on these factors. Haemophilus influenzae type b (Hib), Streptococcus pneumoniae, and Neisseria meningitidis cause ...

A 29 year old male developed paraplegia during the acute phase of meningococcal meningitis. Possible mechanisms for this unusual complication are discussed and the literature regarding spinal cord complications of pyogenic meningitis is reviewed.

INTRODUCTION: Bacterial meningitis is a life-threatening illness resulting from bacterial infection of the meninges. In Cuba there are about 500 cases of bacterial meningitis every year. Still a little part of these cases is caused by the bacteria N. meningitidis as meningococcal disease (clinical forms: meningitis, septicaemia or both), despite the disease being under vaccination control since...

The authors report a case of deficiency of the eighth component of complement in a young adult with a history of three episodes of meningitis; one of them proved to be meningococcal. The literature was reviewed and meningitis due to Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients was demonstrated. Meningococcal disease may be the first m...

Neisseria meningitidis is an important cause of bacterial meningitis, particularly in infants over three months old and in teenagers. The relative importance of meningococcal disease over invasive Haemophilus influenzae disease has increased following the introduction ofHib capsular vaccines in 1990. In about one fifth of infections with Neisseria meningitidis the organism causes a predominantl...

The aims were to (1) investigate the aetiology of probable meningococcal disease, where a clinical diagnosis is made in the absence of laboratory data, and (2) evaluate the impact of the Men C vaccination programme in England and Wales. Multiple linear regression analyses were carried out using data reported to Enhanced Surveillance of Meningococcal Disease (ESMD) and laboratory reports of isol...

Meningococcal lipopoly(oligo)saccharide (LOS) is a major inflammatory mediator of fulminant meningococcal sepsis and meningitis. Highly purified wild-type meningococcal LOS and LOS from genetically defined mutants of Neisseria meningitidis that contained specific mutations in LOS biosynthesis pathways were used to confirm that meningococcal LOS activation of macrophages was CD14/Toll-like recep...

BACKGROUND Meningococcal meningitis is a major cause of disease worldwide, with frequent epidemics particularly affecting an area of sub-Saharan Africa known as the "meningitis belt". Neisseria meningitidis group A (MenA) is responsible for major epidemics in Africa. Recently W-135 has emerged as an important pathogen. Currently, the strategy for control of such outbreaks is emergency use of me...

Neurology 2012;79:1528–1529 In bacterial meningitis, lysis of bacteria during treatment triggers the release of cytokines that increase intrathecal inflammation. Studies with animals have shown that adjunctive treatment with glucocorticoids reduces both the inflammatory response and neurologic sequelae.1 Such treatment in humans, however, has been controversial for decades despite 44 clinical t...